Mortality prediction model for patients with bladder urothelial tumor after radical cystectomy

Jiménez, Gema Del Pozo; Amo, F. Herránz; Ríos, D. Subirá; Fernández, E. Rodríguez; Chomón, G. Bueno; Gárate, M. Moralejo; Merino, R. Durán; Patiño, Gregorio Escribano; Rodríguez, J. Carballido; Fernández, C. Hernández

doi:10.1016/j.acuroe.2019.08.010

Cited by 1 publication

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Spain, no studies of trends in the use of NAC in MIBC exist; however, data can be extrapolated from different published series. These data indicate that between 3.1 and 4.3% [15,16] of patients received NAC before 2010, with a percentage increase in its current use varying between 29.7% and 60.7% [16][17][18]. The indication for surgery in geriatric patients have been increasingly positive as surgical experience and life expectancy have improved [19], with cystectomy becoming established as a safe procedure in selected elderly patients [20,21].…”

Section: Introductionmentioning

confidence: 99%

Mortality Trends Related to Bladder Cancer in Spain, 1999–2018

Sanz

Martínez-Cayuelas

Gil-Guillén

et al. 2022

JCM

View full text Add to dashboard Cite

Bladder cancer (BC) is an important cause of premature mortality (PM, <75 years). Spain has one of the highest BC mortality rates in Europe. The objective of this study was to analyse BC mortality trends between 1999 and 2018 in Spain. The study was based on data from the National Institute of Statistics (Instituto Nacional de Estadística—INE). Age-adjusted mortality rates (AAMRs) were calculated by sex and age group. A trend analysis was performed using Joinpoint regression models and years of potential life lost (YPLL). Mortality in men resulting from BC decreased in all age groups studied. This was not observed in women, for whom mortality only decreased in the ≥75 age group. Deaths due to BC occurred prematurely in 38.6% of men and in 23.8% of women, which indicated a greater impact on YPLL in men compared to women. Over the last 20 years, there has been a significant decrease in BC mortality rate, except in women under 75 years of age. Despite this temporal trend of decreasing mortality, BC continues to have a significant impact on YPLL, mainly in men. Given this context, it is important to direct more resources towards prevention and early diagnosis strategies to correct this situation.

show abstract